E-LIB Suche - Ergebnisse für: Dahan, Franck

1

A design platform for 90-nm leakage reduction techniques:

, In: Proceedings of the 42nd annual Design Automation Conference,

Royannez, Philippe ; Mair, Hugh ; Dahan, Franck... - p. 549-550 , 2005

Link: https://dl.acm.org/doi/1..

2

Constitutional mismatch repair deficiency–associated brain ..:

Brugières, Laurence ; Grill, Jacques ; Wimmer, Katharina...
Neuro-Oncology Advances. 1 (2019) 1 - p. , 2019

Link: https://doi.org/10.1093/..

3

Advanced age does not increase morbidity after total thyroi..:

Christou, Niki ; Blanchard, Claire ; Pattou, François...
The American Journal of Surgery. 217 (2019) 4 - p. 767-771 , 2019

Link: https://doi.org/10.1016/..

4

Does intraoperative neuromonitoring of recurrent nerves hav..:

Mirallié, Éric ; Caillard, Cécile ; Pattou, François...
Surgery. 163 (2018) 1 - p. 124-129 , 2018

Link: https://doi.org/10.1016/..

5

EPID-09. CMMRD (CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY) ..:

Guerrini-Rousseau, Léa ; Colas, Chrystelle ; Wimmer, Katharina...
Neuro-Oncology. 20 (2018) suppl_2 - p. i82-i82 , 2018

Link: https://doi.org/10.1093/..

6

Long-term efficacy and safety of rituximab in IgG4-related ..:

Ebbo, Mikael ; Grados, Aurélie ; Samson, Maxime...
PLOS ONE. 12 (2017) 9 - p. e0183844 , 2017

Link: https://doi.org/10.1371/..

7

Prognostic value of PLA2R autoimmunity detected by measurem..:

Pourcine, Franck ; Dahan, Karine ; Mihout, Fabrice...
PLOS ONE. 12 (2017) 3 - p. e0173201 , 2017

Link: https://doi.org/10.1371/..

8

Chemoradiotherapy with FOLFOX plus cetuximab in locally adv..:

Lledo, Gérard ; Huguet, Florence ; Chibaudel, Benoist...
European Journal of Cancer. 56 (2016) - p. 115-121 , 2016

Link: https://doi.org/10.1016/..

9

Nab-paclitaxel plus gemcitabine for metastatic pancreatic a..:

Portal, Alix ; Pernot, Simon ; Tougeron, David...
British Journal of Cancer. 113 (2015) 7 - p. 989-995 , 2015

Link: https://doi.org/10.1038/..

10

Guidelines for time-to-event end-point definitions in trial..:

Bonnetain, Franck ; Bonsing, Bert ; Conroy, Thierry...
European Journal of Cancer. 50 (2014) 17 - p. 2983-2993 , 2014

Link: https://doi.org/10.1016/..

11

Optimal Cut Points for Quality of Life Questionnaire-Core 3..:

Diouf, Momar ; Bonnetain, Franck ; Barbare, Jean-Claude...
The Oncologist. 20 (2014) 1 - p. 62-71 , 2014

Link: https://doi.org/10.1634/..

12

The added value of quality of life (QoL) for prognosis of o..:

Diouf, Momar ; Filleron, Thomas ; Barbare, Jean-Claude...
Journal of Hepatology. 58 (2013) 3 - p. 509-521 , 2013

Link: https://doi.org/10.1016/..

13

A switch from GnRH agonist to GnRH antagonist in castration..:

Masson-Lecomte, Alexandra ; Guy, Laurent ; Pedron, Philippe...
World Journal of Urology. 31 (2012) 2 - p. 339-343 , 2012

Link: https://doi.org/10.1007/..

14

Development and validation of a new prognostic score of dea..:

Tournoux-Facon, Caroline ; Paoletti, Xavier ; Barbare, Jean-Claude...
Journal of Hepatology. 54 (2011) 1 - p. 108-114 , 2011

Link: https://doi.org/10.1016/..

15

Time until definitive quality of life score deterioration a..:

Bonnetain, Franck ; Dahan, Laetitia ; Maillard, Emilie...
European Journal of Cancer. 46 (2010) 15 - p. 2753-2762 , 2010

Link: https://doi.org/10.1016/..